$VPHM Company News Morgan Stanley drops Google from best

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2013 at 7:42 PM

$VPHM Company News

Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com

Biotech Stock Roundup: Vanda Soars, Sarepta Slumps - Analyst Blog 11:33 a.m. Today - Zacks.com
UPDATE: Stifel Downgrades ViroPharma Following News of Proposed Acquisition by Shire Pharmaceuticals 8:19 a.m. Nov. 19, 2013 - benzinga.com
Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Nov. 11, 2013 - TheStreet.com

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Nov. 11, 2013 - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Nov. 11, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photronics Faces Legal Heat: Key Investor Steps Now

Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...

Stronghold's Unfulfilled Promise May Cost Coachella Millions

Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...

Allegra RMS Wins Big at Red Dot Award 2026

Amid the hustle and bustle of the airport industry, AirportLabs is turning heads and grabbing awards. Their latest triumph? Allegra RMS taking home a Red Dot Award in the Digital Solutions category. Quite the feather in their cap, proving once again they’ve got a knack for navigating the skies of innovation. Breaking Tradition with Intuitive Design Airports have long...

Innovative SOV Launches for Offshore Wind Revolution

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

University of Phoenix Boosts Networking Strategies

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...

TECNO POVA 8 Pro 5G: Blending Speed with Style

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

OCI Faces Legal Hurdles Amid Merger Efforts

OCI Global Gets Twist Thrown Into Merger Plans OCI Global's strategic maneuver with Orascom Construction is hitting a snag. Value8 N.V. has thrown a wrench in the works by filing a petition with Amsterdam's Enterprise Chamber. Looks like this little courtroom tango could pump the brakes on the proposed merger deal. Now, if you're holding shares, it's time to pay attention...

Safety and Wellbeing as Key Business Strategy Focus

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Better's 90-Day Plan: Growth Amidst Governance Gamble

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...